MELOSO BAR - AN OVERVIEW

The introduction of nicotinamide to be a nicotine replacement in e-cigarette and smokeless products represents a major regulatory obstacle with the FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to act as a sedative at high dosages6. The statements created by Nicotine River, ECBlend, and also other distributors